Published in

Taylor and Francis Group, Leukemia & Lymphoma, 8(62), p. 1897-1906, 2021

DOI: 10.1080/10428194.2021.1897805

Links

Tools

Export citation

Search in Google Scholar

Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study

Journal article published in 2021 by Ilaria Rizzello, Michele Cavo ORCID, Luca Dozza, Elena Rivolti, Maria Teresa Petrucci, Valerio De Stefano, Elisabetta Antonioli, Patrizia Tosi, Mattia D’Agostino, Sonia Morè, Alessandro Gozzetti ORCID, Michele Cea, Simona Barbato, Paola Tacchetti, Lucia Pantani and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO